Intensity Therapeutics Inc (INTS)
4.87
-0.05
(-1.02%)
USD |
NASDAQ |
Jul 02, 16:00
4.90
+0.03
(+0.62%)
After-Hours: 20:00
Intensity Therapeutics Enterprise Value: 56.28M for July 2, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| July 02, 2024 | 56.28M |
| July 01, 2024 | 56.97M |
| June 28, 2024 | 56.69M |
| June 27, 2024 | 56.97M |
| June 26, 2024 | 57.10M |
| June 25, 2024 | 59.30M |
| June 24, 2024 | 59.16M |
| June 21, 2024 | 56.01M |
| June 20, 2024 | 53.54M |
| June 18, 2024 | 56.83M |
| June 17, 2024 | 53.81M |
| June 14, 2024 | 56.28M |
| June 13, 2024 | 55.05M |
| June 12, 2024 | 55.87M |
| June 11, 2024 | 57.65M |
| June 10, 2024 | 55.05M |
| June 07, 2024 | 55.05M |
| June 06, 2024 | 57.78M |
| June 05, 2024 | 57.10M |
| June 04, 2024 | 58.51M |
| June 03, 2024 | 56.69M |
| May 31, 2024 | 57.65M |
| May 30, 2024 | 57.24M |
| May 29, 2024 | 55.87M |
| May 28, 2024 | 57.79M |
| Date | Value |
|---|---|
| May 24, 2024 | 58.75M |
| May 23, 2024 | 59.02M |
| May 22, 2024 | 58.06M |
| May 21, 2024 | 55.87M |
| May 20, 2024 | 58.06M |
| May 17, 2024 | 56.55M |
| May 16, 2024 | 59.43M |
| May 15, 2024 | 55.73M |
| May 14, 2024 | 50.11M |
| May 13, 2024 | 44.35M |
| May 10, 2024 | 44.35M |
| May 09, 2024 | 41.06M |
| May 08, 2024 | 40.92M |
| May 07, 2024 | 41.20M |
| May 06, 2024 | 40.92M |
| May 03, 2024 | 42.43M |
| May 02, 2024 | 44.35M |
| May 01, 2024 | 42.29M |
| April 30, 2024 | 42.98M |
| April 29, 2024 | 45.45M |
| April 26, 2024 | 43.32M |
| April 25, 2024 | 43.32M |
| April 24, 2024 | 44.21M |
| April 23, 2024 | 45.04M |
| April 22, 2024 | 42.98M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
13.14M
Minimum
Nov 16 2023
119.80M
Maximum
Dec 13 2023
55.08M
Average
54.87M
Median
Jan 30 2024
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 3.015M |
| Palatin Technologies Inc | 20.32M |
| iBio Inc | 25.20M |
| Theriva Biologics Inc | -11.33M |
| Oragenics Inc | 4.218M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.603M |
| Total Expenses (Quarterly) | 4.743M |
| EPS Diluted (Quarterly) | -0.34 |
| Earnings Yield | -44.59% |